Geographic differences in the contribution of ubiA mutations to high-level ethambutol resistance in Mycobacterium tuberculosis

Subramanya Lingaraju, Leen Rigouts, Aditi Gupta, Jongseok Lee, Alaine Nyaruhirira Umubyeyi, Amy L. Davidow, Susan German, Eun Jin Cho, Ji Im Lee, Sang Nae Cho, Cheon Tae Kim, David Alland, Hassan Safi

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Ethambutol (EMB) resistance can evolve through a multistep process, and mutations in the ubiA (Rv3806c) gene appear to be responsible for high-level EMB resistance in Mycobacterium tuberculosis. We evaluated the prevalence of ubiA and embB (Rv3795) mutations in EMB-resistant strains originating from Africa and South Korea. No differences in embB mutation frequencies were observed between strains from both origins. However, ubiA mutations were present in 45.5% ± 6.5% of the African EMB-resistant isolates but in only 9.5% ± 1.5% of the South Korean EMB-resistant isolates. The ubiA mutations associated with EMB resistance were localized to regions encoding the transmembrane domains of the protein, whereas the embB mutations were localized to regions encoding the extramembrane domains. Larger studies are needed to investigate the causes of increased ubiA mutations as a pathway to high-level EMB resistance in African countries, such as extended EMB usage during tuberculosis treatment.

Original languageEnglish
Pages (from-to)4101-4105
Number of pages5
JournalAntimicrobial agents and chemotherapy
Volume60
Issue number7
DOIs
Publication statusPublished - 2016 Jul

Fingerprint

Ethambutol
Mycobacterium tuberculosis
Mutation
Republic of Korea
Mutation Rate
Tuberculosis

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Lingaraju, Subramanya ; Rigouts, Leen ; Gupta, Aditi ; Lee, Jongseok ; Umubyeyi, Alaine Nyaruhirira ; Davidow, Amy L. ; German, Susan ; Cho, Eun Jin ; Lee, Ji Im ; Cho, Sang Nae ; Kim, Cheon Tae ; Alland, David ; Safi, Hassan. / Geographic differences in the contribution of ubiA mutations to high-level ethambutol resistance in Mycobacterium tuberculosis. In: Antimicrobial agents and chemotherapy. 2016 ; Vol. 60, No. 7. pp. 4101-4105.
@article{8a3eb239c0784596b8bd60989da15f31,
title = "Geographic differences in the contribution of ubiA mutations to high-level ethambutol resistance in Mycobacterium tuberculosis",
abstract = "Ethambutol (EMB) resistance can evolve through a multistep process, and mutations in the ubiA (Rv3806c) gene appear to be responsible for high-level EMB resistance in Mycobacterium tuberculosis. We evaluated the prevalence of ubiA and embB (Rv3795) mutations in EMB-resistant strains originating from Africa and South Korea. No differences in embB mutation frequencies were observed between strains from both origins. However, ubiA mutations were present in 45.5{\%} ± 6.5{\%} of the African EMB-resistant isolates but in only 9.5{\%} ± 1.5{\%} of the South Korean EMB-resistant isolates. The ubiA mutations associated with EMB resistance were localized to regions encoding the transmembrane domains of the protein, whereas the embB mutations were localized to regions encoding the extramembrane domains. Larger studies are needed to investigate the causes of increased ubiA mutations as a pathway to high-level EMB resistance in African countries, such as extended EMB usage during tuberculosis treatment.",
author = "Subramanya Lingaraju and Leen Rigouts and Aditi Gupta and Jongseok Lee and Umubyeyi, {Alaine Nyaruhirira} and Davidow, {Amy L.} and Susan German and Cho, {Eun Jin} and Lee, {Ji Im} and Cho, {Sang Nae} and Kim, {Cheon Tae} and David Alland and Hassan Safi",
year = "2016",
month = "7",
doi = "10.1128/AAC.03002-15",
language = "English",
volume = "60",
pages = "4101--4105",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "7",

}

Lingaraju, S, Rigouts, L, Gupta, A, Lee, J, Umubyeyi, AN, Davidow, AL, German, S, Cho, EJ, Lee, JI, Cho, SN, Kim, CT, Alland, D & Safi, H 2016, 'Geographic differences in the contribution of ubiA mutations to high-level ethambutol resistance in Mycobacterium tuberculosis', Antimicrobial agents and chemotherapy, vol. 60, no. 7, pp. 4101-4105. https://doi.org/10.1128/AAC.03002-15

Geographic differences in the contribution of ubiA mutations to high-level ethambutol resistance in Mycobacterium tuberculosis. / Lingaraju, Subramanya; Rigouts, Leen; Gupta, Aditi; Lee, Jongseok; Umubyeyi, Alaine Nyaruhirira; Davidow, Amy L.; German, Susan; Cho, Eun Jin; Lee, Ji Im; Cho, Sang Nae; Kim, Cheon Tae; Alland, David; Safi, Hassan.

In: Antimicrobial agents and chemotherapy, Vol. 60, No. 7, 07.2016, p. 4101-4105.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Geographic differences in the contribution of ubiA mutations to high-level ethambutol resistance in Mycobacterium tuberculosis

AU - Lingaraju, Subramanya

AU - Rigouts, Leen

AU - Gupta, Aditi

AU - Lee, Jongseok

AU - Umubyeyi, Alaine Nyaruhirira

AU - Davidow, Amy L.

AU - German, Susan

AU - Cho, Eun Jin

AU - Lee, Ji Im

AU - Cho, Sang Nae

AU - Kim, Cheon Tae

AU - Alland, David

AU - Safi, Hassan

PY - 2016/7

Y1 - 2016/7

N2 - Ethambutol (EMB) resistance can evolve through a multistep process, and mutations in the ubiA (Rv3806c) gene appear to be responsible for high-level EMB resistance in Mycobacterium tuberculosis. We evaluated the prevalence of ubiA and embB (Rv3795) mutations in EMB-resistant strains originating from Africa and South Korea. No differences in embB mutation frequencies were observed between strains from both origins. However, ubiA mutations were present in 45.5% ± 6.5% of the African EMB-resistant isolates but in only 9.5% ± 1.5% of the South Korean EMB-resistant isolates. The ubiA mutations associated with EMB resistance were localized to regions encoding the transmembrane domains of the protein, whereas the embB mutations were localized to regions encoding the extramembrane domains. Larger studies are needed to investigate the causes of increased ubiA mutations as a pathway to high-level EMB resistance in African countries, such as extended EMB usage during tuberculosis treatment.

AB - Ethambutol (EMB) resistance can evolve through a multistep process, and mutations in the ubiA (Rv3806c) gene appear to be responsible for high-level EMB resistance in Mycobacterium tuberculosis. We evaluated the prevalence of ubiA and embB (Rv3795) mutations in EMB-resistant strains originating from Africa and South Korea. No differences in embB mutation frequencies were observed between strains from both origins. However, ubiA mutations were present in 45.5% ± 6.5% of the African EMB-resistant isolates but in only 9.5% ± 1.5% of the South Korean EMB-resistant isolates. The ubiA mutations associated with EMB resistance were localized to regions encoding the transmembrane domains of the protein, whereas the embB mutations were localized to regions encoding the extramembrane domains. Larger studies are needed to investigate the causes of increased ubiA mutations as a pathway to high-level EMB resistance in African countries, such as extended EMB usage during tuberculosis treatment.

UR - http://www.scopus.com/inward/record.url?scp=84977567408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84977567408&partnerID=8YFLogxK

U2 - 10.1128/AAC.03002-15

DO - 10.1128/AAC.03002-15

M3 - Article

C2 - 27139478

AN - SCOPUS:84977567408

VL - 60

SP - 4101

EP - 4105

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 7

ER -